The chemistry, physiology and pathology of pH in cancer.

Cell survival is conditional on the maintenance of a favourable acid-base balance (pH). Owing to intensive respiratory CO2 and lactic acid production, cancer cells are exposed continuously to large acid-base fluxes, which would disturb pH if uncorrected. The large cellular reservoir of H(+)-binding...

Full description

Bibliographic Details
Main Authors: Swietach, P, Vaughan-Jones, R, Harris, A, Hulikova, A
Format: Journal article
Language:English
Published: 2014
_version_ 1797077010576572416
author Swietach, P
Vaughan-Jones, R
Harris, A
Hulikova, A
author_facet Swietach, P
Vaughan-Jones, R
Harris, A
Hulikova, A
author_sort Swietach, P
collection OXFORD
description Cell survival is conditional on the maintenance of a favourable acid-base balance (pH). Owing to intensive respiratory CO2 and lactic acid production, cancer cells are exposed continuously to large acid-base fluxes, which would disturb pH if uncorrected. The large cellular reservoir of H(+)-binding sites can buffer pH changes but, on its own, is inadequate to regulate intracellular pH. To stabilize intracellular pH at a favourable level, cells control trans-membrane traffic of H(+)-ions (or their chemical equivalents, e.g. ) using specialized transporter proteins sensitive to pH. In poorly perfused tumours, additional diffusion-reaction mechanisms, involving carbonic anhydrase (CA) enzymes, fine-tune control extracellular pH. The ability of H(+)-ions to change the ionization state of proteins underlies the exquisite pH sensitivity of cellular behaviour, including key processes in cancer formation and metastasis (proliferation, cell cycle, transformation, migration). Elevated metabolism, weakened cell-to-capillary diffusive coupling, and adaptations involving H(+)/H(+)-equivalent transporters and extracellular-facing CAs give cancer cells the means to manipulate micro-environmental acidity, a cancer hallmark. Through genetic instability, the cellular apparatus for regulating and sensing pH is able to adapt to extracellular acidity, driving disease progression. The therapeutic potential of disturbing this sequence by targeting H(+)/H(+)-equivalent transporters, buffering or CAs is being investigated, using monoclonal antibodies and small-molecule inhibitors.
first_indexed 2024-03-07T00:11:39Z
format Journal article
id oxford-uuid:7970b7bb-0371-4684-b76b-eb809b280611
institution University of Oxford
language English
last_indexed 2024-03-07T00:11:39Z
publishDate 2014
record_format dspace
spelling oxford-uuid:7970b7bb-0371-4684-b76b-eb809b2806112022-03-26T20:37:25ZThe chemistry, physiology and pathology of pH in cancer.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:7970b7bb-0371-4684-b76b-eb809b280611EnglishSymplectic Elements at Oxford2014Swietach, PVaughan-Jones, RHarris, AHulikova, ACell survival is conditional on the maintenance of a favourable acid-base balance (pH). Owing to intensive respiratory CO2 and lactic acid production, cancer cells are exposed continuously to large acid-base fluxes, which would disturb pH if uncorrected. The large cellular reservoir of H(+)-binding sites can buffer pH changes but, on its own, is inadequate to regulate intracellular pH. To stabilize intracellular pH at a favourable level, cells control trans-membrane traffic of H(+)-ions (or their chemical equivalents, e.g. ) using specialized transporter proteins sensitive to pH. In poorly perfused tumours, additional diffusion-reaction mechanisms, involving carbonic anhydrase (CA) enzymes, fine-tune control extracellular pH. The ability of H(+)-ions to change the ionization state of proteins underlies the exquisite pH sensitivity of cellular behaviour, including key processes in cancer formation and metastasis (proliferation, cell cycle, transformation, migration). Elevated metabolism, weakened cell-to-capillary diffusive coupling, and adaptations involving H(+)/H(+)-equivalent transporters and extracellular-facing CAs give cancer cells the means to manipulate micro-environmental acidity, a cancer hallmark. Through genetic instability, the cellular apparatus for regulating and sensing pH is able to adapt to extracellular acidity, driving disease progression. The therapeutic potential of disturbing this sequence by targeting H(+)/H(+)-equivalent transporters, buffering or CAs is being investigated, using monoclonal antibodies and small-molecule inhibitors.
spellingShingle Swietach, P
Vaughan-Jones, R
Harris, A
Hulikova, A
The chemistry, physiology and pathology of pH in cancer.
title The chemistry, physiology and pathology of pH in cancer.
title_full The chemistry, physiology and pathology of pH in cancer.
title_fullStr The chemistry, physiology and pathology of pH in cancer.
title_full_unstemmed The chemistry, physiology and pathology of pH in cancer.
title_short The chemistry, physiology and pathology of pH in cancer.
title_sort chemistry physiology and pathology of ph in cancer
work_keys_str_mv AT swietachp thechemistryphysiologyandpathologyofphincancer
AT vaughanjonesr thechemistryphysiologyandpathologyofphincancer
AT harrisa thechemistryphysiologyandpathologyofphincancer
AT hulikovaa thechemistryphysiologyandpathologyofphincancer
AT swietachp chemistryphysiologyandpathologyofphincancer
AT vaughanjonesr chemistryphysiologyandpathologyofphincancer
AT harrisa chemistryphysiologyandpathologyofphincancer
AT hulikovaa chemistryphysiologyandpathologyofphincancer